Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study

Bayard, Cornelia; Ledergerber, Bruno; Flepp, Markus; Lecompte, Thanh; Moulin, Estelle; Hoffmann, Matthias; Weber, Rainer; Staehelin, Cornelia; Di Benedetto, Caroline; Fux, Christoph A; Tarr, Philip E; Hasse, Barbara; Calmy, Alexandra

doi:10.1093/ofid/ofx177

Scientific article

English

Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study

ContributorsBayard, Cornelia; Ledergerber, Bruno; Flepp, Markus; Lecompte, Thanh; Moulin, Estelle; Hoffmann, Matthias; Weber, Rainer; Staehelin, Cornelia; Di Benedetto, Caroline; Fux, Christoph A; Tarr, Philip E; Hasse, Barbara; Calmy, Alexandra

Published inOpen Forum Infectious Diseases, vol. 4, no. 4, ofx177

Publication date2017

Abstract

HIV-infected individuals have an increased risk of avascular bone necrosis (AVN). Antiretroviral therapy (ART) and particularly protease inhibitors (PI) have been implicated as a risk factor. We aimed to study the associations of ART with the occurrence of AVN among Swiss HIV Cohort Study participants (SHCS).

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

VIH/SIDA (930)

Citation (ISO format)

BAYARD, Cornelia et al. Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study. In: Open Forum Infectious Diseases, 2017, vol. 4, n° 4, p. ofx177. doi: 10.1093/ofid/ofx177

Article (Published version)

Identifiers

PID : unige:112381
DOI : 10.1093/ofid/ofx177
PMID : 29026869

Journal ISSN2328-8957

400views

199downloads

Creation06/11/2018 16:16:00

First validation06/11/2018 16:16:00

Update15/03/2023 15:17:06

Status update15/03/2023 15:17:05

Last indexation31/10/2024 12:17:18

Archive ouverte UNIGE

Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study

Technical informations